Alzheimer’s quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval

Alzheimer’s quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval

https://ift.tt/zqJpe5W

John Carroll

via Endpoints https://endpts.com

July 6, 2022 at 01:35AM